Cite
FRI-153 High prevalence of steatotic liver disease and systemic inflammation in hereditary fructose intolerance (HFI) patients independent of age, BMI and the presence of metabolic syndrome.
MLA
Delgado, Teresa Cardoso, et al. “FRI-153 High Prevalence of Steatotic Liver Disease and Systemic Inflammation in Hereditary Fructose Intolerance (HFI) Patients Independent of Age, BMI and the Presence of Metabolic Syndrome.” Journal of Hepatology, vol. 80, June 2024, pp. S693–94. EBSCOhost, https://doi.org/10.1016/S0168-8278(24)01976-7.
APA
Delgado, T. C., Cano, A., Mercado-Gómez, M., Buque, X., Alonso, C., Serrano-Macia, M., Alcalde, C., Belanger-Quintana, A., Cañedo-Villarroya, E., Hualde, L. C., Chumillas-Calzada, S., Correcher, P., García-Arenas, D., Gómez, I., Hernández, T., Izquierdo-García, E., Chicano, D. M., Morales, M., Pedrón-Giner, C., & Jáuregui, E. P. (2024). FRI-153 High prevalence of steatotic liver disease and systemic inflammation in hereditary fructose intolerance (HFI) patients independent of age, BMI and the presence of metabolic syndrome. Journal of Hepatology, 80, S693–S694. https://doi.org/10.1016/S0168-8278(24)01976-7
Chicago
Delgado, Teresa Cardoso, Ainara Cano, Maria Mercado-Gómez, Xabier Buque, Cristina Alonso, Marina Serrano-Macia, Carlos Alcalde, et al. 2024. “FRI-153 High Prevalence of Steatotic Liver Disease and Systemic Inflammation in Hereditary Fructose Intolerance (HFI) Patients Independent of Age, BMI and the Presence of Metabolic Syndrome.” Journal of Hepatology 80 (June): S693–94. doi:10.1016/S0168-8278(24)01976-7.